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Objective: Cancer treatment decision making process is particularly fraught with
challenges for young women because the treatment can affect their reproductive
potential. Among many factors affecting the process, fears of cancer progression
and recurrence can also be important psychological factors. Our aim is to apply
Common-Sense Model and shared decision-making model to explore experiences
of treatment decision-making women of reproductive age who were diagnosed with
gynaecological or breast cancer and the influence of fertility issues and fears of cancer
progression and recurrence.
Method: We conducted telephone interviews with 24 women who were diagnosed
with gynaecological or breast cancer aged 18–45, who finished active treatment within 5
years prior to study enrolment and had no known evidence of cancer recurrence at the
time of participation. They were recruited from three NHS oncology clinics in Scotland
and online outlets of cancer charities and support organisations. We analysed the data
using Braun and Clarke’s thematic analysis method as it allows for both inductive and
deductive analyses.
Results: We identified five main themes pertaining to treatment-related decision-making
experiences and fertility issues and fear of progression and recurrence: Becoming aware
of infertility as a potential consequence of cancer treatment; Balancing-prioritising cancer
and fertility; Decisions about treatments; Evaluation of treatment decisions; and The
consequences of treatments. Sub-themes have also been reported. Different factors
such as whether the cancer is breast or gynaecological, physicians’ willingness of
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discussing fertility, influence of others in decision-making, childbearing and relationship
status as well as fear of cancer recurrence emerged as important.
Conclusion: The importance of physicians directly addressing fertility preservation
in the process of treatment decision-making and not treating it as an “add-on” was
evident. Satisfaction with treatment decisions depended on both the quality of the
process of decision making and its outcome. Fear of recurrence was present in
different parts of the adaptation process from illness perceptions to post-treatment
evaluation of decisions. Both Common-Sense Model and shared decision-making model
were helpful in understanding and explaining young women’s experience of treatment
decision-making and fertility concerns.
Keywords: fear of cancer recurrence, fear of cancer progression, fertility, treatment decision-making, common-
sense model, breast cancer, gynaecological cancer, shared decision-making model
INTRODUCTION
The incidence of cancer in the United Kingdom has been
increasing since the early 1990s (Cancer Research UK, 2020a).
Notably among adults aged 25–49, cancer rates between 1993
and 2017 have increased by 21% (Cancer Research UK, 2020a).
In this cohort, women were significantly more likely than men
to be diagnosed with cancer, and between 2015 and 2017,
four out of 10 were diagnosed with breast cancer (Cancer
Research UK, 2020a). Cervical, ovarian, and endometrial cancer
accounted for 8, 5.2, and 2.6% of all cancers in this group,
respectively (Cancer Research UK, 2020a,b,c). Overall, 60%
of women aged 25–49 diagnosed with cancer in the UK
between 2015 and 2017 faced a disease that could have a
considerable impact on their reproductive potential, either
because of the disease itself or because of potential consequences
of treatment.
The impact of cancer treatments on fertility contributes
to poorer psychological well-being including higher levels of
distress (Sobota and Ozakinci, 2018; Logan et al., 2019) and
decreased quality of life (Sobota and Ozakinci, 2014) among
young women with cancer. Oncofertility has emerged as a novel
field to address fertility needs of young people with cancer.
Research has shown the beneficial effect of discussing fertility
preservation as part of oncology consultation (Ussher et al.,
2018) and providing young women with decision aids to facilitate
decisionmaking around fertility preservation (Wang et al., 2019).
While fertility preservation is increasingly available to cancer
patients, with national guidelines acknowledging its importance
and encouraging to provide the service (National Institute for
Health Care Excellence, 2017; Ethics Committee of the American
Society for Reproductive Medicine, 2018; Oktay et al., 2018),
multiple barriers to accessing fertility preservation including age,
relationship status, timing of decisions, and institutional factors
still exist (Crawshaw et al., 2009; Lee et al., 2011; Niemasik et al.,
2012; Yee et al., 2012; Hershberger et al., 2013a,b; Kirkman et al.,
2013; Ruddy et al., 2013; Snyder and Tate, 2013; Corney and
Swinglehurst, 2014; Corney et al., 2014; Garvelink et al., 2015).
Another important factor contributing to decisions about
fertility preservation is fear of cancer progression and recurrence
(Gorman et al., 2011; Lee et al., 2011; Hershberger et al.,
2013b; Kirkman et al., 2013; Snyder and Tate, 2013; Garvelink
et al., 2015). Fear of cancer progression and recurrence
is the “fear, worry or concern relating to the possibility
that cancer will come back or progress” (Lebel et al.,
2016; p. 3,265). It can affect patients’ treatment choices and
in a study among breast cancer patients, Stafford et al.
(1998) have demonstrated that fear of cancer recurrence was
one of the main reasons women tended to choose more
radical treatment.
Considering the complexity of cancer treatment-related
decision making, we conducted a qualitative study exploring
the experiences of treatment decision-making of young women
diagnosed with breast or gynaecological cancer and the influence
of fertility issues and fears of cancer recurrence and progression
on these decisions.
We chose to apply two theoretical models—the Common-
Sense Model (CSM) (Leventhal et al., 2004) and shared decision-
making model (Elwyn et al., 2012) to study the decision-making
processes. In this article, we are reporting on our findings
relating to the importance of fertility, fear that cancer may
recur or progress, and illness perceptions as defined by CSM on
treatment-related decision making, however the broader project
has findings that relate to other aspects of the CSM and decision-
making process.
The CSM is a model of self-regulation widely used to
study illness perceptions and management. The model asserts
that in response to a health threat, the individual forms both
cognitive representations (illness perceptions) and emotional
representations (e.g., fear and worry) of the threat. There are
five dimensions to illness perceptions: identity (the label for the
threat and the symptoms), perceived cause, perceived timeline,
perceived consequences, and perceived curability/controllability
of the threat. Both of the representations mean that the
individual goes through a process of developing coping
procedures which are then evaluated in an appraisal process
of whether they worked or not. It has been shown that
patients’ treatment decision-making processes are frequently
driven by their own lay perceptions of illness and treatment
(Charles et al., 1998).
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Shared decision-making model has also relevance in the
context of young women’s experience of treatment decision-
making and consideration to be given to fertility preservation.
The involvement in the process of treatment decision-making
can be an empowering experience for the patient (Whitney et al.,
2004) and another strategy to cope with cancer.What is crucial in
the shared decision-making model is the bidirectional exchange
of information whereby the physician shares his or her medical
knowledge as well as the opinions about different treatment
modalities with the patient and the patient in turn provides the
information about his or her values and preferences regarding
treatments as well as sharing the pre-existing knowledge he or she
has about his or her condition. Once the information exchange
process has taken place, both the patient and the physician
enter the deliberation stage where information is discussed
in an interactional manner. In this process of negotiation,
a decision regarding treatment is reached and implemented
(Charles et al., 1999).
MATERIALS AND METHODS
Design
Eligible women were invited to participate in an interview
and were approached at the time of their outpatient clinic
appointment in three UK-based hospitals (Edinburgh, Dundee,
Kirkcaldy) or via online outlets of UK-based cancer charities
(between October 2014 and May 2015). Based on Cancer
Research UK and Office of National Statistics data (Local
Government Association, 2015; Cancer Research UK, 2020a,b,c),
the cumulative incidence of breast, ovarian, cervical, and womb
cancer was ∼97 in 100,000 women aged 25–49 in 2015. With
numbers of potentially eligible women being small we anticipated
we may encounter difficulties recruiting for the study, therefore
we used this mixed approach strategy (NHS and cancer support
organisations) to (1) reach a wider patient population and
maximise recruitment potential, and (2) attempt to recruit as
diverse and representative a sample of women as possible.
Women who consented to take part were interviewed over
the phone. Braun and Clarke thematic analysis 2006 was
used to explore women’s experiences of cancer treatment-
related decision-making.
This study has been reported in accordance with the COREQ
criteria (Tong et al., 2007) (see Appendix 1). See the interview
guide in Appendix 2.
Participants
Women meeting the following inclusion criteria were invited
to participate:
• received a diagnosis of breast or gynaecological cancer
between the ages of 18–45 years old;
• were menstruating at the time of diagnosis;
• had chemotherapy (neo-adjuvant or adjuvant) as part of their
treatment if they were diagnosed with breast cancer;
• finished active treatment (with the exception of endocrine
therapy for breast cancer) within 5 years prior to
study enrolment;
• had no known evidence of cancer recurrence at the time
of participation;
• spoke English or Polish.
We chose to focus on breast and gynaecological cancers for
several reasons. First, these are some of the most common
cancer diagnoses among women aged 25 to 49 (Cancer Research
UK, 2020a,b,c). Second, their treatments can either impair
fertility, or make one’s fertility status post-treatment uncertain.
As the literature seems to suggest that it is women’s subjective
perception of, rather than the objective fertility status that affect’s
women’s well-being (Sobota and Ozakinci, 2014), we decided to
include womenwho had any treatment with the potential to affect
fertility. This included women who had chemotherapy for breast
cancer as it is associated with uncertainty regarding individual
fertility which may be difficult to predict (Wallace et al., 2005;
Knobf, 2006; Duffy and Allen, 2009); women with early stage
cervical cancer who underwent a cone biopsy or trachelectomy
because while both treatments preserve fertility, they can be
associated with adverse obstetric outcomes such as second
trimester miscarriage (with a rate nearly twice as high as for the
general population), and pre-term birth (Tirlapur et al., 2017).
Also, according to the recent review, up to 61% of women who
had a trachelectomy need artificial reproductive technologies to
conceive (Tirlapur et al., 2017) which can be associated with
uncertainty about one’s fertility. Both atypical hyperplasia and
early stage endometrial cancer (often grouped together), can be
treated with progestogens, however, fertility outcomes are poorer
than in the general population (Wei et al., 2017). The gold
standard treatment for endometrial cancer—hysterectomy and
bilateral salpingo-oophorectomy (Amant et al., 2018), will have
the same impact on women’s fertility as cytoreductive surgery
for ovarian cancer, which is by far the most common surgical
treatment for ovarian cancer due to the delay in its diagnosis
(Cancer Research UK, 2017).
Although childbearing status affects the degree of importance
women attach to fertility when diagnosed with cancer (Gorman
et al., 2010; Canada and Schover, 2012; Ruddy et al., 2014) we did
not include it in our inclusion and exclusion criteria and decided
to recruit both women who did and those who did not have
children prior to diagnosis. This was to achieve a wide variety of
experiences and data saturation.
Participants were provided with a standard research pack
including a cover letter, a participant information sheet, an opt-
in form (not for participants recruited online), two copies of the
consent form, an interview schedule, a debriefing form and two
stamped-addressed envelopes. Women who opted in to take part
were then contacted via phone to fill out the consent form and
agree the interview date.
To recruit for the study, we relied on convenience sampling.
This was to decrease the pressure to participate in the project
investigating sensitive topics. Nonetheless, our sampling strategy
yielded participants with a wide range of characteristics in
terms of cancer diagnoses and treatments, age, relationship and
childbearing status, and the use of fertility preservation. While
the inclusion criteria indicate that Polish-speaking women would
be included in the study, these participants were not actively
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sought. Although two were approached for participation, they
decided not to participate.
Overall, 56 women expressed interest in taking part in the
study and 24 were recruited (10 via clinics and 14 via online
outlets; participation rate = 43%). Thirty-two women who
initially expressed interest in participating, but did not make
further contact with the research team were not re-approached,
hence the reasons for non-participation remain unknown.
Data Collection
All women were interviewed by the same researcher (AS) by
phone. Interview by phone was selected primarily to facilitate
data collection from participants who were recruited via online
outlets and thus could potentially live in any part of the UK but
they also possess othermerits important for this study. Thismode
of interviewing allows the participant to remain anonymous,
permits privacy, diminishes social pressure, and thus enables
participants to disclose sensitive or intimate information more
freely (Novick, 2008).
The interviews were guided by an interview schedule (see
Appendix 2). Each interview started with an opening question
asking the participant to describe the circumstances of her
cancer diagnosis and the treatment process. Each interview ended
with an open-ended question and this is where participants
had a chance to speak about other issues they faced because
of cancer diagnosis at a young age. Answers yielded additional
themes that were not directly related to the research questions
yet enriched the understanding of the participants’ cancer
experiences. Participants were asked to provide basic socio-
demographic details (current age, country of origin, relationship
status, childbearing status, monthly income before tax, and
the highest education level) and disease characteristics (type of
cancer, stage of cancer at diagnosis, types of cancer treatment
received and date of diagnosis) if these were not mentioned
during the interview. The interviews lasted on average 55min
(range= 22–121 min).
All interviews were digitally recorded and transcribed
verbatim. Identifying details were removed from the transcripts
and each transcript was assigned a numeric code. Notes taken
during the interviews and reflections written after the interviews
were assigned the same numeric code to link all the relevant
participant data.
Analysis
The data were analysed using the principles of thematic analysis
outlined by Braun and Clarke (2006) which was conceived as a
standalone data analysis method for “identifying, analysing, and
reporting patterns (themes) within data” (p. 79). The analysis
followed six steps of: (1) Familiarisation with data, (2) Generation
of initial codes, (3) Searching for themes, (4) Reviewing themes,
(5) Defining and naming themes, and (6) Producing the report.
One of the important advantages of thematic analysis is its
flexibility. As opposed to other methods of qualitative analysis
it is not tied to any particular epistemological or theoretical
approach (Braun and Clarke, 2006). It can, therefore, be adapted
to the researcher’s needs in terms of epistemological or theoretical
framework. Another benefit of thematic analysis lies in the
fact that, while many qualitative methods are purely inductive,
thematic analysis can be used in both an inductive and deductive
manner. A method that would allow for a deductive approach
and application of specific theoretical frameworks to the data
was essential for this study and thematic analysis fulfilled these
criteria. The CSM was chosen from the outset and guided both
the design and the analysis of the data while shared decision-
making model was selected to guide the data analysis.
Notably, Braun and Clarke’s thematic analysis can be used
as a realist method focusing on peoples’ personal experiences
and the meanings they attach to their lived realities, a
constructionist approach where these meanings and experiences
are considered an effect of discourses operating in society,
or finally a contextualist approach which sits between realism
and constructionism, and acknowledges that meanings and
experiences, while grounded in one’s reality are also a factor
of broader societal and cultural constructs (Braun and Clarke,
2006).
In the inductive stage of our data analysis, we assumed a
realist approach. As a paradigm it is often used to “discover
knowledge” and purports that peoples’ accounts reflect reality
(Madill et al., 2000). By adopting it we aimed to tap into our
participants’ realities and “discover [categories/codes] within
the data” (Madill et al., 2000). Therefore, the derived codes
reflected our participants’ understanding of their experiences and
decision-making processes during cancer treatment in the wider
context of preserving fertility and fear of cancer recurrence. At
the end of this step, these initial codes were categorised into
patterns, and patterns were then used as a foundation to which
we applied our theoretical lens.
In the deductive stage of the analysis, we applied theoretical
frameworks rooted in cognitive psychology of health and illness
(the CSM) and health-related decision making (the shared
decision-making model) to the patterned codes whereby moving
our analysis into the contextualist territory. Contextualism
postulates that all human experience is context specific and
subjective, and that phenomena can be interpreted in multiple
ways (King and Brooks, 2016). These interpretations depend on
the specific context of research and the stance of the researcher.
As such, based on the aforementioned theories, we derived
the final themes from the codes. This approach positions our
analysis within contextual thematic analysis spectrum. This type
of analysis has been successfully used within (Fielden et al., 2011;
Faric et al., 2019) as well as outside of health research (Goldingay
et al., 2018).
From the practical perspective, the interview transcripts were
first read and reread for a thorough familiarisation with the data.
Next, all the transcripts were uploaded to QSR International’s
NVivo 10 Software (NVivo qualitative data analysis Software,
2012) and the first cycle coding method—the descriptive
coding—was applied to the data. Descriptive coding uses short
phrases to summarise topics reoccurring in the data (Saldaña,
2015). Once all the data were coded, the second cycle coding
method—the pattern coding—was applied. The pattern coding
allows for grouping of the descriptive codes and making sense of
the relationships among them (Saldaña, 2015). Through further
reading and rereading of the interviews, secondary codes were
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FIGURE 1 | Data analysis process.
refined to better reflect the data. Up to this point the data analysis
was conducted by one researcher (AS). In the next step, the map
of secondary codes was applied to three out of 24 interviews
by the second researcher (GO). Where discrepancies in coding
between the researchers occurred, these were discussed until a
consensus was reached and codes were clarified and reorganised
to better fit the data.
The analysis up to this point was carried out in an inductive
manner. However, since this study focused particularly on
the experiences of treatment-related decision-making and was
driven by two theoretical models, once the secondary codes
were obtained, the rest of the analysis was conducted in
deductive manner.
This type of analysis, as suggested by Braun and Clarke
(2006), focuses on answering a particular research question and
exploring the theory, rather than on providing the description
of the whole dataset (understood as all the data collected for
the particular project). This approach results in a more detailed
analysis of certain aspect of the dataset—in this case the data
related to treatment decision-making in the context of fears
of cancer progression and recurrence, and fertility. Therefore,
at this point in analysis, all the codes were reviewed again
and those that did not contribute directly to answering any of
the research questions were moved to a separate folder. The
remaining codes were iteratively reread and arranged according
to the main concepts involved in the CSM and shared decision-
making model. Codes categorised as belonging to the same
concepts within the theoretical models were then conceptualised
into internally homogenous and externally heterogeneous
themes. These themes were subsequently discussed within
the research team to assure the credibility and the rigour
of the analysis.
In summary, we initially approached data analysis from a
realist perspective—looking for participants literal experience
of cancer-treatment decision making, and moved into the
contextualist territory—applying the theoretical lens of CSM
and shared decision making model to contextualise the data. At
the same time, our analysis progressed from an inductive to a
deductive one. The CSM informed the study design (interview
schedule), and both inductive and to a greater extent deductive
data analysis, while the shared decision-making model was
applied to the deductive part of the data analysis process. These
processes are represented in Figure 1.
Reflexivity Statement
Qualitative inquiry involves a degree of subjectivity and a neutral
observer as such does not exist (Malterud, 2001), it is therefore
important to outline the researcher’s own effect on the process of
data collection and analysis.
The data for this study was collected and primarily analysed by
AS. This constituted part of her PhD project and all participants
were made aware of this. AS approached this study bringing
in both a personal and a professional perspective, the latter
including that of a junior doctor, psychologist, and researcher.
They have all contributed to how this project was conducted and
are discussed below.
Personally, AS acknowledges that her attitude toward
motherhood is rather ambivalent and she is unsure whether
she wishes to ever have children. However, she believes that
motherhood may be an important experience and one that, if
missed, may cause the feeling of regret. With this in mind,
AS found herself emotionally affected by participants’ storeys.
With some women being very close in age to AS, it proved
difficult for her to completely distance herself from the extremely
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complex decisions these women had to make. Perhaps some of
these emotions were projected on the way the interviews were
conducted and the data subsequently analysed.
Professionally, AS’ perspective of a junior doctor often
prevailed over her identity as a psychologist and she approached
this research project with a practical focus in mind trying to
pinpoint issues that could be changed and improved rather
than to purely look for psychological constructs in the data.
Theoretical frameworks were used while working with the
data and this was to facilitate future practical application of
the findings.
Finally, this was AS’ first qualitative project. The little
experience she had before possibly influenced the way interviews
were conducted, particularly in the early stages of the study.
Someone with more experience in qualitative research, and
specifically in research into sensitive topics might have handled
the interviews differently. AS felt she needed some time to
gain confidence in her own skills and feel comfortable probing
participants about more personal issues.
Ethics Approval
The ethical approval for the project was sought and received from
the East of Scotland Research Ethics Service (REC1) (13/ES/0129)
as well as from the School Ethics Committee at the School of
Medicine, University of St Andrews (MD10852).
RESULTS
Participants
Participant characteristics are presented in Table 1.
Themes
We identified five main themes pertaining to treatment-
related decision-making experiences and fear of progression
and recurrence among young women diagnosed with breast or
gynaecological cancer: Becoming aware of infertility as a potential
consequence of cancer treatment; Balancing-prioritising cancer
and fertility; Decisions about treatments; Evaluation of treatment
decisions; and The consequences of treatments. Subthemes within
the themes are described in detail. See Figure S1 for the visual
representation of the main themes.
The themes were first organised around the four
components of the CSM: “appraisal of health threat,” “illness
perceptions,” “strategies to cope with illness,” and “appraisal of
coping strategies.”
The appraisal of health threat and illness perceptions are
represented throughout the following themes: Becoming aware
of infertility as a potential consequence of cancer treatment; and
Balancing-prioritising cancer and fertility. Treatment decision-
making processes were conceptualised as a strategy to cope with
the illness and are represented in the theme Decisions about
treatments. The subthemes that were identified within this theme
reflect the concepts of the shared decision-making model as it
pertains to the clinical settings. Finally, the themes Evaluation
of treatment decisions and The consequences of treatments
represent the last component of the CSM—the appraisal of
coping strategies.












Time Since Diagnosis (Years)
0–2 16 (67%)
3–5 8 (33%)
Partnership Status At Diagnosis
Partnered 18 (75%)
Unpartnered 6 (25%)




Less than university education 5 (21%)






Artificial reproductive technologies 4 (17%)




No children 15 (63%)
Child(ren) before diagnosis but not after diagnosis 7 (29%)
No child(ren) before but child(ren) after diagnosis 1 (4%)
Child(ren) before and after diagnosis 1 (4%)
There were elements of “illness perceptions” in The
consequences of treatments theme as well. Traditionally, in
the CSM, the information gained through the appraisal process
feeds back into the coping strategies and allows for their
modification as appropriate to a specific situation. In the case
of treatment decisions, however, that would be impossible
since once treatments had been administered one cannot
take back one’s decision (e.g., to pursue fertility preservation
or not) and opt for a different regimen. One can only cope
with the consequences of these decisions made at the time
under difficult circumstances. The last theme describes these
consequences as well as women’s attempts to cope with
them in a situation where the change of treatment decisions
is impossible.
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Becoming Aware of Infertility as a Potential
Consequence of Cancer Treatment
Often women described experiencing a shock upon receiving a
cancer diagnosis at a young age. There was a disconnect between
the diagnosis and what they perceived themselves to be: a healthy
young woman. In addition to transitioning from being healthy to
a cancer patient, women also became aware of what this meant
for their fertility as a consequence of this disease.
Whether they were diagnosed with gynaecological or breast
cancer, most of the women perceived treatments having a
potential to be detrimental for their fertility. While for some that
was not an issue, others wanted to know what could possibly be
done to spare or preserve their fertility. Two scenarios became
apparent: fertility discussions were either part of the consultation
and initiated by the physicians or they needed to be broached by
the women themselves.
For some women, a member of their clinical team brought up
the topic of fertility in a consultation. Most women appreciated
this, irrespective of whether they were interested in preserving
their fertility. They welcomed the opportunity to receive the
relevant information and be able to consider what it meant for
them. The consequences of those decisions for cancer growth
were highlighted by their clinicians.
I mean the gynaecologist I had was fantastic. Honestly, absolutely
fantastic. And he talked through everything. He also said that if I
didn’t want to go through a hysterectomy just now he could monitor
it over a period of time, they could try and give me . . . oestrogen
I think it was and to see if I would . . . if I could conceive over a
period of time and they would help me . . . But he then told me the
consequences of doing that, which is the cancer could grow quicker,
you know it might be that I could conceive but I couldn’t carry a
child, loads of different things. He explained everything fully, gave
me the pros and cons and then you know, sent me away to think
about it.
P06, womb cancer diagnosed at 35, no children
When fertility discussions constituted a standard part of a
consultation, women had a chance to express their preferences
without having to broach the topic themselves. However, that was
not always the case. When fertility was not a standard part of the
consultation, the onus of initiating the discussion was on women
or their relatives.
So, when I was first diagnosed my husband just happened to . . . say
. . . “Will it affect our chances of having children?” and I’m so glad
he thought of asking that ‘cause I . . . I just wouldn’t have asked it.
‘Cause . . . ‘cause obviously I had lots of other things going on in
my head.
P15, breast cancer diagnosed at 32, no children
On occasion, women had to assume the responsibility for getting
informed regarding fertility preservation. They had to be the
ones to start the conversation and at times even force their
consultants to engage in the discussion about the fertility aspect
of their treatment.
Yeah, it was Dr. [name] who was my first oncologist [inaudible],
but that was only like I said after I . . . stood up and said “Is there
anything we could do to preserve the fertility?” [. . . ] He wasn’t
willing to discuss it. It was only when I approached it . . . and then
he said he would go away and think about it and look at my case.
And it was only when he looked at my case notes and realised I was
young and not like 50—40 and was only . . . like a . . . grade I and
grade Ia that he decided to send me for the clinical trial.
P02, womb cancer diagnosed at 32, no children
In those cases, women often felt that fertility was not important
to their physicians and was treated as an “add-on” or something
extra and not part of standard care. Some even questioned
whether fertility would have been discussed at all had they not
broached the subject themselves.
Balancing—Prioritising Cancer and Fertility
Faced with a life-threatening illness, women weighed the
importance of fertility against the desire to survive the disease.
Through this process they formulated their priorities which were
used to guide their treatment decisions.
Women underwent a process of “balancing-prioritising
cancer and fertility” in their decisions. Regardless of how
important fertility was at the time of diagnosis, most women
reported that they wanted to give themselves the best chance at
surviving the cancer and prevent any future recurrence.
Because I was worried maybe if it was gonna be growing to
something . . . more serious. And I was worried it was gonna turn
into cancer, so I just wanted everything cleared out.
P22, borderline ovarian tumour diagnosed at
39, no children Some of the participants were
prepared to undergo the most aggressive treatments to ensure
that no stray cancer cells were left behind even if that meant
having to deal with the treatment side-effects and increasing the
risk of losing fertility to cancer.
Women who already had children, whether they considered
their family complete or not, felt their existing children and
getting better for them were their primary concern. Even if
fertility preservation was presented as an option, they felt they
could not afford an attempt at the potential cost of worsening
their prognosis.
We were very much of the mind, that we have to try our best to
. . . for me to stay alive for my son, for my child and, you know, then
not . . . so that kind of meant that . . . we said that preserving fertility
just wasn’t an opt . . . you know, getting . . . doing an IVF effectively
wasn’t an option.
P10, breast cancer diagnosed at 32, 1 child
before and 1 child after diagnosis
Women who did not have children were the ones for whom
finding this balance between preserving their fertility and the
desire to survive cancer was the most difficult since the two were
often valued as equally important. However, even this group of
participants admitted that it would only make sense to preserve
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fertility if they were at some point well-enough to actually become
pregnant and have a child.
And he’s [the oncologist]. . . he’s always said, which I agree, it’s a
balance of . . . it’s alright having a baby but you’ve got to be there,
to be around to bring it up (laughter). . . . It’s quite a stark way of
saying it.
P01, breast cancer diagnosed at 32, no children
The balancing-prioritising process certainly differed between
women who considered fertility important at the time of their
cancer diagnosis and those who did not. However, within
the group of women for whom fertility was important, this
process also differed between women diagnosed with breast vs.
gynaecological cancers. The difference appeared to be related to
the distinct consequences that treatment decisions had for the
two groups.
For women with breast cancer, receiving chemotherapy
did not automatically mean infertility but meant that their
post-cancer fertility status would be uncertain. Although
chemotherapy could hasten the menopause, if their menstrual
cycles returned after chemotherapy, they could still conceive
naturally. Therefore, even without fertility preservation, there
was hope that their fertility would remain unaffected by cancer
treatments. Additionally, in the case of breast cancer, fertility
preservation was a process separate from cancer treatments.
Women could choose to undergo fertility preservation as an
additional procedure which involved a separate decision-making
process to the one about cancer treatments. Although potentially
not neutral to their cancer prognosis, for women with breast
cancer, fertility preservation was not directly related to their
cancer treatments.
For women with gynaecological cancers, on the other hand,
the two were intrinsically intertwined and therefore the desire
to preserve fertility and potentially forgo some of the cancer
treatments could have a much bigger impact on their prognosis
and survival. There was also no element of uncertainty—once
they had radical treatment, their chance of carrying a pregnancy
was taken away permanently.
These differences could potentially explain why women
diagnosed with gynaecological cancers were much more hesitant
while progressing through the balancing-prioritising process.
Despite these difficulties however, most of them did choose to go
forward with treatments, even at the cost of fertility.
Only one woman positioned herself in opposition to other
participants and clearly stated that her priority was her fertility
and save it if at all possible, even at the cost of her longer-
term prognosis. After weighing the pros and cons she eventually
decided to opt in for a radical trachelectomy instead of
a hysterectomy.
The long-term survival wasn’t . . . my longer-term prognosis didn’t
really ever enter my mind. I would say it did for my family, it
did for my partner. I think it may have been there vaguely in the
background for me but all I wanted to do was that my fertility
wasn’t taken away and that my desire to carry a child wasn’t taken
away. And I didn’t want it taken away by cancer if I could at all
help it.
P13, cervical cancer diagnosed at 31,
no children.
Decisions About Treatments
Although women might have prioritised their fertility and
survival in different ways, there were similarities in terms of
the processes that all of them went through. Also, even though
some of the decisions needed to be made at the time of diagnosis
and others later, the processes involved in both were very
much alike. Henceforth, these main processes are presented
for all the participants and all the decisions together under
the following subthemes: Informing vs. involving others; and
Alignment of treatment preferences between women and their
physicians, and its consequences. Where differences occurred
between treatment decisions and decisions relating specifically
to fertility preservation or between decisions made at the time
of diagnosis and those made later, these are presented within
the subthemes. Factors specific to fertility preservation and
interrupting the tamoxifen treatment are summarised separately
under the subtheme Specific considerations related to immediate
fertility preservation and tamoxifen.
Informing vs. Involving Others
Physicians were automatically involved in the decision-making
process. Irrespective of the type of treatment women were
referring to, the vast majority considered their consultants’
opinion to be the most important factor that swayed or even
dictated their treatment-related decisions entirely. Yet, there
were also other people such as partners and parents whose
opinions women took into consideration while making decisions.
There was a clear difference between the degree of
involvement of the significant others in the decisions that
concerned only cancer treatments and the ones that could also
potentially impact on fertility. Treatment decisions, in general,
were made between the patient and her clinical team. Women
informed their parents and partners about what was going
to happen rather than sought their advice. Although family
members lent their support to patients’ decisions, they rarely
played an active role.
I come from amedical family so of course I spoke to family members
and discussed what my consultants were talking to me about [. . . ]
but I was solely guided by my consultants.
P14, breast cancer diagnosed at 27, no children
On the other hand, decisions that involved fertility were more
often discussed with the significant others. Partnered women
often described these decisions as joint decisions. Since fertility
was something that couples negotiated between themselves,
women considered it important for their partners to partake
in decision-making which could potentially affect that aspect
of their relationship. Negotiating when to stop the tamoxifen
in order to conceive was also described as a joint decision.
Partnered women wanted to establish their priorities as a couple
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and make a decision in line with those priorities, regardless of its
final outcome.
We sort of decided between us that, yes, we did want a family, we
wanted that chance. So rather than it being sort of completely taken
away from us . . . at least we’d have the opportunity.
P15, breast cancer diagnosed at 33, no children
With respect to interrupting the tamoxifen, women specifically
emphasised the importance of partner’s involvement because of
the consequences (e.g., increased risk of cancer recurrence) that
such a decision could carry.
I think he [partner] would have been happy for me to just go and
make a decision but I so much felt like I needed that to be a joint
decision. If . . . the shit hits the fan basically . . . I couldn’t ever have
him saying “You kind of . . . you wanted this, you went off and did
it” kind of . . . to me that wasn’t . . . I wasn’t comfortable with that
. . . it had to be what we kind of all wanted.
P10, breast cancer diagnosed at 32, 1 child
before and 1 child after diagnosis
Women who were in the early stages of their relationships felt
that cancer brought forward the discussions and decisions about
having children together with their new partners and they did not
necessarily feel comfortable with that. Yet, they still did prefer
to make decisions about treatments potentially affecting fertility
jointly with their partners.
Not only was it kind of absorbing the fact that I had cancer, it was
also putting my partner and I in a position of, well we haven’t really
spoken about this because we haven’t been together a great deal of
time . . . to suddenly, “do we want to have children?” I know I did
and we had spoken about it briefly but not to the point of “well am
I gonna lose my fertility or keep my fertility?.” So, we did have some
time to think about it. And it just . . . to me it was always everything
that I wanted to do, to keep fertility. Yeah and we agreed that that
would be what we would do.
P13, cervical cancer diagnosed at
31, no children
Single women often consulted with their parents and sought
their advice regarding the treatment options.
I spoke to my dad and he obviously then . . . said to me . . . he said
“I’d rather you still be with me that having kids. I want you to be
healthy.” And he kind of reassured me . . . and said to me, you know
“Have the full operation and you can always adopt, you can always
do fostering and stuff like that.”
P22, borderline ovarian tumour diagnosed at
39, no children.
Alignment of Treatment Preferences
Between Women and Their Physicians, and
Its Consequences
With respect to fertility, women engaged in the prioritising-
balancing process described in the Balancing-prioritising cancer
and fertility theme. This process enabled women to clarify
the value fertility had for them at the time of diagnosis
and incorporate it into the decision-making processes about
treatments involving the fertility aspect accordingly. Women’s
preferences, however, were not sufficient to guide treatment
decisions. The priority their doctors gave to fertility and patients’
childbearing desires equally played a role in the treatment
decision-making process. The extent to which the priorities of
these two parties involved in the process were in line with each
other affected the decision-making.
For women for whom fertility was not an issue, the situation
was fairly straightforward since neither they nor their physicians
had to factor it into the treatment plan. For womenwhowished to
consider fertility while making treatment decisions and who were
under the care of physicians who acknowledged their priorities,
the situation was similar and boiled down to discussing the
available options and drawing the treatment plan around them.
The situation became more complicated for women who
considered fertility while making decisions and who were under
the care of the physicians whose priorities differed from theirs.
Some women clearly considered preserving their fertility equally
important to treating cancer whereas physicians treated it as an
“add-on.” This created a confusing situation for women who, on
the one hand, wanted to follow their consultants’ lead and accept
the treatments that were suggested to them and on the other,
prioritised their fertility differently from their physicians. While
many women in this situation ended up accepting treatments
suggested by their physicians, some went against the advice they
received or consulted another physician.
So within the first week of me being diagnosed I was referred by
my oncologist to a gynaecologist at the hospital. And I went to see
him and it was, it was quite an awful meeting really because he
basically said he wasn’t happy doing anything with me because I
had oestrogen-positive breast cancer . . . which, it was just a really
awkward meeting, my partner was there with me and we thought it
felt like a bit, like we’re being interviewed about our relationship
and he was very down on it all and said that he would not do
anything at all until after I had chemo and I was sort of trying to
explain “Well, I’ve been told that actually . . . the chemo is going to
affect my eggs and my ovaries possibly and my fertility so shouldn’t
we try and do it before and . . . ” And anyway he just wasn’t, he
wasn’t interested and wasn’t going to help me at all. [. . . ] A friend
of the family went to a consultant [fertility specialist] so my partner
and me went to see him, I think this was like the day before my
surgery. So it was all like a real mad rush to get it done. And he
said “Yeah don’t worry at all.” He was brilliant actually. He’d said
that he’d treated other women with tumours and there was a pill
I could take during the IVF process that would keep my oestrogen
levels down and he was just really good and really sympathetic and
just sort of gelled with him very quickly.
P01, breast cancer diagnosed at 32, no children
On the other side of the spectrum were women who opted in for
the most aggressive treatments. Some of them saw this as the only
way to restore their quality of life which deteriorated because of
the symptoms they had prior to diagnosis. However, the most
frequent reason for wanting radical treatments was the fear that
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by doing less, some of the cancer cells would be left behind and
the cancer could eventually recur.
If I hadn’t had chemotherapy . . . there would be a higher risk
of recurrence so, I think everything that was thrown at me and
everything that was on offer . . . it can only be positive because you
want to throw everything at it.
P07, breast cancer diagnosed at 39, no children
The physicians acquiesced to patients’ preferences regarding
treatments as long as they thought these were reasonable.
Women’s preferences and their consideration were therefore
tempered by their physicians’ perception of need for treatment.
Specific Considerations Related to
Immediate Fertility Preservation and
Tamoxifen
In addition to above influences, there were certain factors women
spoke about that related specifically to fertility-related decisions.
These included institutional issues, the timing of the initial
treatment decisions, and the length of time participants needed
to be on the tamoxifen before they could try for a pregnancy.
The availability or services and efficiency of the referral
pathways acted as facilitators to receiving fertility sparing or
preserving treatment. However, not all women who wanted to
take advantage of these services were easily able to do that.
Even though assisted conception services for cancer patients are
available under the health care scheme, some patients could not
get an appointment on time or were disqualified from their use
based on age or type of diagnosis. Some of these patients decided
to organise a consultation privately. The lack of experience in
navigating through the private healthcare system while trying to
set up a fertility appointment added to their burden at the time of
diagnosis. Cost of the procedures was another issue they had to
resolve before pursuing fertility preservation privately.
So I did feel like in those 3–4 weeks of . . . from being diagnosed I
was going pretty much every day to see an oncologist, or for a blood
test or for a different scan or . . . that every day was taken up with
. . . preparing for my operation and lots of medical appointments
. . . and then on top of that I’m having, I was having to research
and try and find somebody to help me [with fertility]. And that was
very, very difficult and exhausting I suppose. [. . . ] sat trying to get
funding, or sat trying to get an appointment for this and that. So,
the whole process could have been very much made a lot easier for
me and if there was . . . someone to go to.
P01, breast cancer diagnosed at 32, no children
Timing of the decisions and haste with which they needed to
be made constituted further challenges. Women’s impression
was that cancer treatment was needed urgently. They explained
how their physicians stressed the importance of them getting
their treatments as soon as possible and without undue delays.
Although time pressure did not necessarily affect the decisions
for womenwith gynaecological cancers who could opt for fertility
sparing surgery (e. g., trachelectomy), it was a barrier for women
who wanted to take advantage of the assisted conception services.
When we saw doctor [name], on that first time she said, “Look, we
can . . . I can put you forward for egg collection and IVF but that’s
gonna be another month to 6–8 weeks that I don’t particularly want
to wait based on your diagnosis. So unless you are absolutely dead
set on that, my advice is that we start treatment straight away.”
P16, breast cancer diagnosed at 32, 1 child
before cancer
Although in a different way, time also played a role in
decisions regarding the tamoxifen. Women’s biggest issue when
considering whether to stop the tamoxifen was the length of time
they should take it for before they could safely interrupt it to
conceive. Neither the research, nor the opinions of the doctors
were clear with respect to that which made women uncertain as
to what the best course of action would be.
There hasn’t been that much that I can find on the Internet,
and articles, medical articles about the risks of re-occurrence with
coming off tamoxifen before you are advised to and trying for a
baby and the effects of hormones on you etc. So, trying to find
that information, reading it through and then sort of making that
informed decision is important to both of us.
P01, breast cancer diagnosed at 32, no children.
Evaluation of Treatment Decisions
The over-riding feeling among women irrespective of the type of
decisions they made was that these decisions were right for their
particular circumstances. Most women who preserved fertility
were grateful they were able to do this. Women found comfort
in that their reproductive choices were still theirs as opposed to
being entirely out of their hand because of cancer treatments.
They also expressed relief at avoiding the regret that they could
have potentially felt, had they not acted to preserve fertility. All
these women, however, felt well and as far as they were concerned
their actions to preserve fertility were not in any way detrimental
to their health. Only one woman who had recurrence scares
subsequently to her treatment questioned her decision about
trying to preserve her fertility at all cost.
And it was . . . almost nowmademe feel like it was the right decision
back then in July and August to have the trachelectomy but with
complications that have come up and scares that have come up
from them, I now feel a bit like a ticking time bomb in that it was
right then but I have elements of doubt as to whether perhaps a
hysterectomy may have been . . . a better option?
P13, cervical cancer diagnosed at 31,
no children
Similar to women who preserved fertility, those who did not
also felt they made the right decisions regarding their course
of treatment. Some found making those decisions easy. Others,
despite finding them less straightforward felt that at least they
were in control of what was happening to them. One woman,
however, felt that she made a mistake by deciding to undergo the
treatment whereby her fertility was permanently lost.
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I wish I hadn’t done it [had hysterectomy]. It was the biggest mistake
in my life.
P05, womb cancer diagnosed at 31, 1
child before cancer.
The Consequences of Treatments
Irrespective of whether women decided to preserve their
fertility throughout cancer treatments, their treatment decisions
inevitably had consequences for their post-cancer lives. Fertility-
related consequences of cancer treatments are discussed in the
subtheme Cancer-related factors controlling reproductive choices.
Cancer-Related Factors Controlling
Reproductive Choices
Cancer diagnosis and treatments, irrespective of whether the
participant decided to preserve fertility, changed the context of
women’s reproductive decisions. It took away this spontaneity
and brought about additional cancer-related external and
internal factors that constrained the realisation of women’s
fertility-related plans. The external factors included dependence
on healthcare professionals and other people to help women
either conceive or become a parent through alternative means.
Fear of recurrence was an internal factor that acted as a barrier to
having children.
Women who pursued artificial reproductive technologies
observed that their embryos could only be released to them after
a certain amount of time had passed since their treatment.
I don’t think you’re allowed to have those embryos released prior to
2 years after treatment.
P07, breast cancer diagnosed at 39, no children
Although they were in a position to make a decision whether to
use them, they were not in control of when that would happen.
Not only were the healthcare professionals involved in deciding
when to release the embryos to the patients but also in carrying
out the procedure of the embryo transfer which meant that their
assistance was crucial for women.
I think fertility is the big one because it’s just taken away the . . . the
sort of . . . I suppose being able to spontaneously think about having
a family. That has to be nowmore of a . . . more steps in place before
being able to do that.
P15, breast cancer diagnosed at 33, no children
Since women’s decisions regarding the length of time they should
be on the tamoxifen were also highly influenced by the advice
they were given by their physicians, the time of their eventual
pregnancy was again only partially within their control.
Once we’d started the IVF cycle and I went back to see my surgeon,
at the time he said that I’d need chemo, he then said “Well the
evidence shows that tamoxifen is more effective for 10 years” so in
my mind then I was thinking “Well we’re [inaudible] eggs collected
we have, you know, we’re gonna have embryos but I’m not gonna be
able to do anything with them because in 10 years” time I’ll be, you
know, 44.” Originally when we started thinking about doing IVF
cycle . . . and it would have been 5 years on tamoxifen, that kind of
would have been fine cause I’d be sort of 39ish so . . .
P15, breast cancer diagnosed at 33, no children
Women who underwent trachelectomy for cervical cancer noted
multiple possible pregnancy complications that awaited them
should they decide to conceive. They were aware that they
would require help from the obstetric services to carry the
pregnancy and deliver safely. Although these women preserved
the ultimate choice of whether to have children, at the same
time cancer diagnosis deprived them of the full control over their
reproductive decisions. The help of the healthcare professionals
became an inherent part of their reproductive choices.
Additionally, women who received the trachelectomy felt as if
by the fact that they were offered this procedure, they were also
somehow expected to eventually conceive. They were either given
a specific timeframe within which they should try for a child or
reminded by their physicians that the procedure was done in view
of them getting pregnant at some point.
On more than one occasion by more than one person it’s been
suggested that this operation was given to me almost, and in fact
one professional used that expression . . . it was given to me . . .
because of the situation I was in, you know, 31 and childless kind
of thing. And . . . they almost, I kind of . . . I get the impression
I’m meant to be grateful for that. I mean, don’t get me wrong, I’m
grateful for the fact that and the end of the day it saved my life and
it was the best option. But it’s almost like by not having a child yet I
am . . . I don’t know what the best way to put it is. It’s almost like I
am insulting them by not seeing it through.
P08, cervical cancer diagnosed at 31,
no children
Even women who could not or decided not to preserve fertility
noted that their reproductive choices were to a certain extent
medicalised. Pursuing surrogacy or adoption depended not only
on their wish to do so, but also on their health status and being
free of cancer for a specific length of time.
Like I know I’ve still got options of like adoption and like a hope that
I can still go down this route. I know you’ve got to be cancer-free for
5 years. And I just hope that I can . . .
P02, womb cancer diagnosed at 32, no children
Women who wished to pursue alternative parenting routes also
feared the process of their parenting competencies being assessed
by other people—a situation that would not have occurred had
they not had cancer. For them the ability to extend their families
was limited by other people’s judgement—potential surrogate
mothers in the case of surrogacy, or social services in the case
of adoption.
As opposed to these external factors, fear of recurrence
was an internal factor which also affected women’s plans to
have children. Whether they were thinking about biological or
alternative parenting, women questioned if it was responsible to
have a child knowing that cancer could come back at any time.
Some of them thought it would be selfish to pursue pregnancy.
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The threat of cancer recurrence was of particular importance
to women who were diagnosed with breast cancer. They often
linked their disease to hormonal issues and therefore perceived
interrupting tamoxifen in order to conceive as potentially
increasing their risk of recurrence. They stressed the importance
of not “cutting corners” with their endocrine treatment to
avoid a situation whereby driven by a desire to have a child
they would provoke a recurrence and eventually leave a child
without a mother. Women who already had children before
cancer questioned whether they had the right to take the risk
extending their families at the potential cost of their existing
children’s well-being.
Yeah . . . well I do worry about . . . like . . . is there a risk of it coming
back and . . . and . . . and . . . leaving a child without a mother is an
awful thought . . . and whether that’s not a responsible thing to do.
P04, breast cancer diagnosed at 29, no children.
DISCUSSION
The aim of this qualitative study was to gain an in-depth
understanding of young women’s cancer treatment decision-
making and the extent to which, as well as the reason why, their
decisions were influenced by fertility issues and fear of cancer
recurrence and progression. The study was guided by the CSM
and shared decision-making model therefore the findings are
discussed within these theoretical frameworks.
Our data showed that women’s responses to the cancer
diagnosis often involved a shock and a sense of disbelief of
having cancer at their age. The formation of illness perceptions
as a result of the cancer diagnosis soon revolved around its
consequences, particularly in relation to fertility. Discussion with
their physicians on the impact of treatment on fertility and how
fertility could be preserved was expressed as important part of
their experience.
Women often appreciated having their physicians initiate a
conversation around fertility preservation. Although for some
women these discussions occurred in the course of their first
consultation and were initiated by a member of their clinical
team, for others this was not the case and these women were
often disappointed by their physicians trying to avoid the topic
and treating it like an “add-on.” This is in line with the findings
from the literature which suggest that providing women with
fertility-related information gives them the sense of agency and
control over their lives (Snyder and Tate, 2013) while withholding
the information from them engenders the feelings of lack of
control and powerlessness (Niemasik et al., 2012; Kirkman et al.,
2014). In our study, all of the participants received the relevant
information. Nonetheless, some of them reported that they had
to take the responsibility for initiating the discussions and felt
that had they not done that, the topic might have been ignored.
The literature suggests that upon learning about fertility-
related consequences of cancer treatments women engage in
the process of finding a balance between survival and fertility
(Pellegrini et al., 2010; Gorman et al., 2011; Lee et al., 2011;
Hershberger et al., 2013b). The findings of this study align with
this concept. Regardless of whether fertility was important to
the women, engaging in a balancing and prioritising process
enabled them to consolidate their perception of illness and
clarify their values with respect to the outcome they wanted to
achieve through treatment (to preserve fertility or not). This,
in accordance with the CSM, allowed them then to devise
appropriate coping procedures and action plans to undertake.
Shared decision-making model (Charles et al., 1997) assumes
that for the shared decision-making to occur four conditions
need to be fulfilled. First, there needs to be at least two
participants in the decision-making—the patient and the
physician. However, Charles et al. (1999) specify that this is
the minimum number and emphasise that other people such
as family members can also be involved. Second, both (or all)
parties need to be willing to participate in the process in the
sense that both (or all) agree to share the decision-making. If one
side does not wish to participate, the decision-making cannot be
shared. Third, the information needs to be exchanged between
the physician and the patient. The information here encompasses
not only the medical knowledge and opinions about different
treatments on the part of the physician but also patient’s opinions
and values that he or she wishes to take into account while
making treatment decisions. The information exchange usually
happens through the deliberation process where all opinions
are weighed and reviewed. Finally, through negotiations, the
treatment decision needs to be reached and agreed upon by all
parties involved in the process. The assumptions of the shared
decision-making model do not preclude the patient from simply
agreeing to the treatment suggested by one’s physician. However,
if one feels coerced to do so, then the process of the decision-
making cannot be considered shared.
Women in our study sought healthcare professionals’ advice
and wished to be guided by experts with regard to their treatment
choices which is in line with the first two assumptions of
the shared decision-making model. While there is evidence
suggesting that young women are more likely to want to
participate in cancer treatment decision making (Kane et al.,
2014), as well as be active players in the decision-making process
compared to their older counterparts (Hamelinck et al., 2018),
research also underlines the importance of eliciting patient’s
preference as to their role in the decision-making process (Weber
et al., 2013; Hamelinck et al., 2018). The concordance between
patient’s desired and actual level of involvement in the decision-
making process, as opposed to the level of involvement alone, is
likely to be associated with the satisfaction with treatment choice
(Keating et al., 2002).
This is also echoed in our study. While both the patients’
and physicians’ preferences played an important role in the
decision-making process in this study, it was the concordance
between them that proved to be critical. When women’s and their
physicians’ preferences with respect to fertility were congruous,
the decision-making took an unproblematic course. However,
when women’s preferences with respect to fertility preservation
differed from their physicians’ priorities, accommodating them
in the decision-making process seemed to become more
problematic. In the latter situation, two scenarios were most
common. One involved women following the expert’s advice at
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the cost of their own fertility-related preferences. In the other,
women acted in accordance with their priorities, even if that
meant searching for second opinions or going against the will of
their physicians.
For the majority of women who may have had particular
preferences with respect to fertility, the desire to follow the
expert’s advice overrode their priorities and dictated their
treatment decisions. However, these women also exhibited
an understanding why physicians were suggesting treatments
which, while lifesaving, could affect fertility. They accepted
that fertility was a price they needed to pay to survive their
diagnosis. Their physicians took the time to explain that to
them.While there might not have been the concordance between
the patients’ and the physicians’ preferences with respect to
fertility in those instances, there was congruence between the
patients’ expectations regarding treatment-decisions and the
physicians’ practise styles. In their review Kiesler and Auerbach
(2006) suggest that it is the latter that matters in terms of
satisfaction with the decision-making processes and subsequent
psychological outcomes.
In our study, having a trustworthy relationship with the
physician facilitated women’s decision-making processes. This
type of a relationship was usually achieved through open
communication, particularly with respect to fertility issues.While
physicians were willing to discuss various treatment options,
the initiation of fertility-related discussions was often up to the
patient. This mirrors the findings of several other studies that
looked at fertility preservation among patients with cancer where
women had to bring the topic up themselves suspecting that it
would not have been addressed at all otherwise (Yee et al., 2012;
Corney and Swinglehurst, 2014; Kirkman et al., 2014).
Some women in our study perceived fertility-related
communication as far from ideal. Research has shown
that physicians frequently have negative preconceptions
about initiating fertility discussions and suggesting fertility
preservation in the cancer setting (Goossens et al., 2014). As
fertility preservation is a time-sensitive issue among women with
breast cancer, and strictly related to cancer treatment among
women with gynaecological cancers, clinicians may feel that
for some patients pursuing any type of fertility preservation is
not a viable option and therefore is omitted in discussions and
shared-decision making. There is evidence that clinicians are
more likely to involve patients in sheared decision-making where
equal treatment options providing an actual choice exist (Kane
et al., 2014).
However, omitting fertility-related discussions completely for
the fear of disagreement between the physician’s and the patient’s
values and excluding it from the shared decision making may
have opposite to the desired effect. Occasionally in our study,
when the physician was reluctant to discuss fertility, women
for whom it was an important topic changed their healthcare
providers, even if that meant eventually having to pay for
the services.
Finally, evidence shows that women who are unsure of
their fertility preferences at the time of diagnosis are more
inclined to follow their physician’s advice with respect to fertility
preservation (Snyder and Tate, 2013). If this advice is not
in favour of fertility preservation, it could potentially lead
to situations where some women opt against it even if their
particular circumstances allow for it. This emphasises the need
for the physicians to create an open-minded and non-judgmental
environment for the patients to at the very least be able to discuss
their fertility concerns and clarify their desires with respect to
post-cancer childbearing. The failure to do so in this study may
not have resulted in missed opportunities at preserving fertility,
however, led some of the women to change their physician or go
against their physician’s advice to ensure that their priorities were
accounted for.
Healthcare professionals were not the only people women
wanted to include in the decision-making. Many of the
partnered women wished for their partners to be involved
in the decisions which could have impact on fertility. They
often described these decisions as “joint.” While this makes for
a complex triadic relationship, a recent review by Gonçalves
et al. (2020) highlights the importance of facilitating partners’
involvement in fertility-related decisions in the context of
cancer. Improved communication of information between the
couple and healthcare providers is suggested to contribute to
better decision making and ultimately, mental health outcomes
(Gonçalves et al., 2020). In the absence of a partner, some of the
single women wished to include their parents in the decision-
making processes. Although not specific to fertility, a study
by Hubbard et al. (2010) points to other benefits of involving
family members in cancer-treatment related decision-making.
The findings of this study suggest that family members can act
as an additional channel of communication with the physicians
as well as aid patients in choosing appropriate treatments.
In this study, we also observed elements of fear of cancer
recurrence impacting on treatment decisions. Radical treatments
were seen as a way of minimising risk of recurrence. The findings
of our study are in line with our review on fear of cancer
recurrence among breast cancer survivors showing how these
fears can impact decisions about pursuing aggressive treatments
as well as post-cancer pregnancy decisions (Ozakinci et al., 2014).
The last phase of the shared decision-making process involves
reaching a treatment decision between the physician and the
patient. An issue specific to fertility preservation reported by
women in this study was the timing of the decisions. Often
women only had a very short window to make their decision
to avoid delaying their cancer treatment. While this evidence
corroborates the findings of the literature that the timing of
fertility-related decisions is limited and can act as a barrier
(Crawshaw et al., 2009; Kirkman et al., 2013; Snyder and Tate,
2013; Garvelink et al., 2015), it also reveals the preferences
that physicians had with respect to their patients’ treatments,
namely that delaying cancer treatments to preserve fertility was
not advisable.
According to the CSM, outcome appraisal is an integral part
of the process of adaptation to a health threat. The information
gained throughout this process feeds back into the organisation
of a health threat perception. The altered representation acts as
new baseline to modulate subsequent coping strategies which
promote adjustment to the illness. Since this study concentrated
specifically on treatment-related decision-making as a strategy
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to cope with cancer diagnosis, the outcome appraisal pertained
to the evaluation of the treatment decisions made by the
participants and their physicians.
The majority of women in this study felt that decisions they
made with respect to treatments were right for their particular
circumstances. Two factors possibly contributed to that—the
satisfaction with the process of the treatment decision-making,
already described earlier and the satisfaction with the outcome of
their decisions.
There were two possible outcomes women could have
achieved through making their treatment decisions—fertility
preservation or lack of thereof. Women who preserved their
fertility were generally happy with this outcome although one
participant (P13) later questioned whether that was the right
thing to do due to cancer recurrence scares she had. Although
most women were satisfied with the decisions they made at
the time of diagnosis, going back to life as they knew it before
cancer proved to be more difficult than some of them might
have expected.
In terms of the CSM, the appraisal of coping procedures
serves to refine them and improve the adjustment to illness.
In many instances it is possible that when one coping strategy
fails or is found unacceptable, one can choose from an array of
other strategies. This process however, does not fully apply to
the case of cancer treatment decisions that can affect fertility.
Women only have one chance at making the “right” decision
because its consequences are irreversible. Any adjustments to
treatment decision-making as a coping strategy can only be made
before any actions are carried out. Once the treatments have
been administered, the feedback loop is interrupted and any
adjustments to treatment decision-making as a coping strategy
become impossible. In the post-treatment phase women were left
to deal with the consequences of their treatments, pertaining to
both fertility and fears of cancer recurrence.
One of the reasons why women decided to preserve fertility
was to preserve their choice, however, this proved to be only
partially effective. Whilst after cancer women were still in charge
of the ultimate decision of whether to have children at all, they
were at the same time constrained in how and when to realise
their fertility-related plans. Studies reviewing the outcomes of
fertility preservation among cancer patients have demonstrated
13–23% utilisation rates of cryopreserved embryos (Barcroft
et al., 2013; Dolmans et al., 2015). It would appear that even
following treatment, cancer continue to have an impact on
reproductive decisions—an irreversible consequence that can
prove challenging to women who preserved fertility.
Limitations and Strengths
Because of the methodology of the study, it has the drawbacks
inherent to qualitative research in that its results cannot be
easily generalizable. The study sample consisted mainly of well-
educated, White, British women and this is the population that
the findings could potentially be extended to. Any extrapolations,
particularly to different cultural setting warrant caution.
It is possible that due to the recruitment strategy, especially the
online method, participants who were interviewed for this study
were a self-selected sample of women particularly interested in
the issue of fertility after cancer. This would mean that the
findings may apply to other women similarly preoccupied by
fertility in the context of cancer.
In this study, we used face to face and online methods to
approach and invite women to take part. Tackling the differences
between these two groups was not the focus of this study,
however, reflecting back on the results the following could
be observed:
1. Among participants recruited using the face to face method
in the NHS clinics were both women who were and those
who were not interested in preserving their fertility at the
time of cancer diagnosis. Hence, this group was potentially
more representative of the population of young women
diagnosed with cancer. Qualitative inquiry does not strive to
be generalizable in statistical terms but rather to provide an
insight into a particular phenomenon (e.g., in the case of this
study it was treatment-related decision-making in the context
of fertility), therefore representativeness of the sample can be
considered less of an issue in qualitative studies compared to
the ones using quantitative approach. However, a sample of
participants with diverse points of view can provide a more
in-depth account of a particular phenomenon and strengthens
the analysis in terms of its credibility through the analysis
of negative cases. It was additionally observed that, in this
study, women who were recruited via the NHS had a rather
positive experience of how their fertility issues at the time
of diagnosis were addressed. Although clinicians were not
informed which of their patients eventually participated in the
study and all data were anonymised, it is possible that women
who had negative experience with treatment provision were
less inclined to take part fearing that their accounts could be
made known to their healthcare providers and this in turn
could affect the care they were receiving.
2. As opposed to the participants recruited via the NHS, the
majority of those who were recruited online reported some
issues with how their fertility concerns were addressed at
the time of their diagnosis. This could be related to the
fact that being informed about the study outside the context
of direct healthcare provision (which is in contrast to the
women approached for participation via the NHS) potentially
made women more confident about and comfortable sharing
negative experiences. It is also possible that women recruited
online were generally more interested in the topic of the study
and therefore less representative of the population of young
women with cancer. As they were not directly approached
for participation, it can be purported that they either actively
searched for information about this particular type of project
(e.g., by accessing the research sections of cancer charities
websites where advertisement of the project was frequently
placed) or their attention was drawn by the project topic
as the advertisement appeared on social media accounts of
cancer charities.
In conclusion, women diagnosed with breast or gynaecological
cancer at a young age undergo a complex process of balancing
the wish to survive cancer diagnosis against their desire to
preserve fertility to enable them to pursue their reproductive
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plans. This is best done when decisions regarding treatments
that are life-saving but could potentially impact on fertility are
shared between women and their physicians. Involvement of
partners is also crucial at the stage where fertility is considered.
Open communication and expression of one’s preferences and
values facilitates the decision-making process. Alignment of
desired and actual level of involvement in the decision-making
as well as the congruence between the patients’ expectations
regarding treatment-decisions and the physicians’ practise styles
contribute to the satisfaction with both the process of the
decision-making and its outcome. It is important to remember
that once treatments are completed, regardless of whether fertility
was preserved or not young women struggle with the limitations
to their reproductive choices.
These findings need to be interpreted accounting for the
limitations of our study. The differences in participants’
experiences of and perspectives on treatment-related decision-
making in the context of fertility based on the recruitment
method (NHS clinics vs. online) could guide recruitment to
future oncofertility studies. For projects aiming to obtain a
more diverse participant sample and investigate treatment-
related decision-making among young women with cancer
from a broader perspective it would be advisable to use
the clinic-based strategy. For projects that wish to focus on
particular issues related to fertility concerns at the time of
diagnosis, and the existing issues in addressing them within
the clinical setting, an online recruitment strategy would
be preferable.
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